ARCHIVES

AVEO’s Tivozanib Sunk by Fundamental Flaw: Higher Overall Survival in the Control Arm

This article is from The Cancer Letter archive.

Vol. 39 No. 18 | May 8, 2013

Download PDF Visit The Full Archive

Related Articles

In Congress: Senate Resolution Includes $15 Billion For NIH In FY99

April 10, 1998

Senate Defeats Attempt To Cut NIH Funds

July 8, 1977

NCI Expects Centers To Increase Cancer Control Efforts Despite Various Obstacles They Face

January 16, 1987

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

In Brief: Construction Grant Transfer To USC Approved; Illinois Director Says NCI Pushed Consortia

January 20, 1978

ACS Says NCI Needs $1.1 Billion, Cites Progress In Prevention, Control

April 29, 1977